Simultaneous determination of 1,5-dicaffeoylquinic acid and its active metabolites in human plasma by liquid chromatography-tandem mass spectrometry for pharmacokinetic studies

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 852, Issue 1-2, 2007, Pages 85-91

  Gu, Ruolan ^a   Dou, Guifang ^a   Wang, Jing ^a   Dong, Junxing ^b   Meng, Zhiyun ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

1,5 Dicaffeoylquinic acid; 1,5 O Diferuoylquinic acid; 1 Caffeoyl 5 feruoylquinic acid; LC MS MS; Pharmacokinetics

Indexed keywords

MATRIX EFFECT; SELECTED REACTION MONITORING (SRM); TANDEM MASS SPECTROMETRY;

BIOASSAY; CORROSION INHIBITORS; ELECTROSPRAY IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHARMACOKINETICS;

METABOLITES;

1 CAFFEOYL 5 FERUOYLQUINIC ACID; 1,5 O DIFERUOYLQUINIC ACID; CYNARINE; DRUG METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG METABOLISM; DRUG STRUCTURE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; ION MONITORING; LIQUID CHROMATOGRAPHY; NORMAL HUMAN; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

CHROMATOGRAPHY, LIQUID; CINNAMATES; HUMANS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 34249672360     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2006.12.055     Document Type: Article

References (24)

1. Moreira R.F., Trugo L.C., de Maria C.A., Matos A.G., Santos S.M., and Leite J.M. Arch. Latinoam. Nutr. 51 (2001) 95
2. Fraisse D., Carnat A., Carnat A.P., Guedon D., and Lamaison J.L. Ann. Pharm. Fr. 61 (2003) 265
3. Parejo I., Viladomat F., Bastida J., and Codina C. Anal. Chim. Acta 512 (2004) 271
4. Yoshimoto M., Yahara S., Okuno S., Islam M.S., Ishiguro K., and Yamakawa O. Biosci. Biotechnol. Biochem. 66 (2002) 2336
5. Li Y., But P.P., and Ooi V.E. Antiviral Res. 68 (2005) 1
6. Kim H.J., and Lee Y.S. Planta Med. 71 (2005) 871
7. Mishima S., Yoshida C., Akino S., and Sakamoto T. Biol. Pharm. Bull. 28 (2005) 1909
8. Mishima S., Inoh Y., Narita Y., Ohta S., Sakamoto T., Araki Y., Suzuki K.M., Akao Y., and Nozawa Y. Bioorg. Med. Chem. 13 (2005) 5814
9. Choi J., Park J.K., Lee K.T., Park K.K., Kim W.B., Lee J.H., Jung H.J., and Park H.J. J. Med. Food. 8 (2005) 348
10. Zhu X., Zhang H., and Lo R. J. Agric. Food Chem. 52 (2004) 7272
11. Sayasith K., Sauve G., and Yelle J. Expert Opin. Ther. Targets 5 (2001) 443
12. Witvrouw M., Van Maele B., Vercammen J., Hantson A., Engelborghs Y., De Clercq E., Pannecouque C., and Debyser Z. Curr. Drug Metab. 5 (2004) 291
13. Makhija M.T. Curr. Med. Chem. 13 (2006) 2429
14. Tarrago-Livak L., Andreola M.L., Fournier M., Nevinsky G.A., Parissi V., de Soultrait V.R., and Litvak S. Curr. Pharm. Des. 8 (2002) 595
15. McDougall B., King P.J., Wu B.W., Hostomsky Z., Reinecke M.G., and Robinson Jr. W.E. Antimicrob. Agents Chemother. 42 (1998) 140
16. Robinson Jr. W.E., Cordeiro M., Abdel-Malek S., Jia Q., Chow S.A., Reinecke M.G., and Mitchell W.M. Mol. Pharmacol. 50 (1996) 846
17. Robinson Jr. W.E., Reinecke M.G., Abdel-Malek S., Jia Q., and Chow S.A. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 6326
18. King P.J., Ma G., Miao W., Jia Q., McDougall B.R., Reinecke M.G., Cornell C., Kuan J., Kim T.R., and Robinson Jr. W.E. J. Med. Chem. 42 (1999) 497
19. Pani A., and Marongiu M.E. Curr. Pharm. Des. 6 (2000) 569
20. Zhu K., Cordeiro M.L., Atienza J., Robinson Jr. W.E., and Chow S.A. J. Virol. 73 (1999) 3309
21. Robinson Jr. W.E. Antiviral Res. 39 (1998) 101
22. Yang B., Meng Z., Dong J., Yan L., Zou L., Tang Z., and Dou G. Drug Metab. Dispos. 33 (2005) 930
23. Yang B., Meng Z.Y., Yan L.P., Dong J.X., Zou L.B., Tang Z.M., and Dou G.F. J. Pharm. Biomed. Anal. 40 (2006) 417
24. Lataillade M., and Kozal M.J. AIDS Patient Care STDS 20 (2006) 489